TY  - GEN
AU  - Brueckmann,Martina
AU  - Wizenmann,Jan
AU  - Hoffmann,Ursula
AU  - Seeger,Markus
AU  - Bewig,Burkhard
TI  - Clinical and laboratory effects of recombinant human activated protein C in the treatment of a patient with sepsis-induced multiple organ failure
SN  - 0049-3848
PY  - 2004///0422
KW  - Adult
KW  - Anti-Bacterial Agents
KW  - Anticoagulants
KW  - pharmacology
KW  - Combined Modality Therapy
KW  - Disseminated Intravascular Coagulation
KW  - prevention & control
KW  - Drainage
KW  - Drug Evaluation
KW  - Drug Therapy, Combination
KW  - therapeutic use
KW  - Female
KW  - Humans
KW  - Knee Joint
KW  - surgery
KW  - Multiple Organ Failure
KW  - blood
KW  - Postoperative Complications
KW  - Protein C
KW  - Recombinant Proteins
KW  - Retropharyngeal Abscess
KW  - drug therapy
KW  - Systemic Inflammatory Response Syndrome
KW  - complications
KW  - Urinary Catheterization
KW  - adverse effects
KW  - Urinary Tract Infections
N1  - Publication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1016/s0049-3848(03)00243-3
ER  -